Simplex Trading’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 3037 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 2973 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 3065 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 2933 |
|
2024
Q2 | – | Sell |
-907
| Closed | -$271K | – | 3024 |
|
2024
Q1 | $271K | Buy |
907
+183
| +25% | +$54.7K | ﹤0.01% | 867 |
|
2023
Q4 | $170K | Buy |
+724
| New | +$170K | ﹤0.01% | 1007 |
|
2023
Q3 | – | Sell |
-183
| Closed | -$31K | – | 2934 |
|
2023
Q2 | $31K | Buy |
+183
| New | +$31K | ﹤0.01% | 1399 |
|
2023
Q1 | – | Sell |
-676
| Closed | -$204K | – | 2984 |
|
2022
Q4 | $204K | Buy |
676
+654
| +2,973% | +$197K | ﹤0.01% | 787 |
|
2022
Q3 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 2475 |
|
2022
Q2 | – | Sell |
-41
| Closed | -$4K | – | 3232 |
|
2022
Q1 | $4K | Sell |
41
-952
| -96% | -$92.9K | ﹤0.01% | 2505 |
|
2021
Q4 | $142K | Buy |
+993
| New | +$142K | ﹤0.01% | 1359 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 3153 |
|
2021
Q2 | – | Sell |
-37
| Closed | -$11K | – | 3231 |
|
2021
Q1 | $11K | Buy |
37
+35
| +1,750% | +$10.4K | ﹤0.01% | 2131 |
|
2020
Q4 | $0 | Sell |
2
-73
| -97% | – | ﹤0.01% | 2715 |
|
2020
Q3 | $23K | Hold |
75
| – | – | ﹤0.01% | 1553 |
|
2020
Q2 | $28K | Buy |
75
+61
| +436% | +$22.8K | ﹤0.01% | 1385 |
|
2020
Q1 | $3K | Buy |
+14
| New | +$3K | ﹤0.01% | 1836 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 2321 |
|
2019
Q3 | – | Sell |
-23
| Closed | -$27K | – | 2284 |
|
2019
Q2 | $27K | Sell |
23
-202
| -90% | -$237K | ﹤0.01% | 1211 |
|
2019
Q1 | $280K | Buy |
225
+181
| +411% | +$225K | ﹤0.01% | 572 |
|
2018
Q4 | $41K | Buy |
+44
| New | +$41K | ﹤0.01% | 1120 |
|
2018
Q3 | – | Sell |
-8
| Closed | -$13K | – | 2397 |
|
2018
Q2 | $13K | Sell |
8
-13
| -62% | -$21.1K | ﹤0.01% | 1619 |
|
2018
Q1 | $33K | Sell |
21
-29
| -58% | -$45.6K | ﹤0.01% | 1267 |
|
2017
Q4 | $84K | Sell |
50
-91
| -65% | -$153K | ﹤0.01% | 1016 |
|
2017
Q3 | $197K | Buy |
141
+122
| +642% | +$170K | 0.01% | 645 |
|
2017
Q2 | $21K | Buy |
+19
| New | +$21K | ﹤0.01% | 1335 |
|